Search research articles
Contact Us
Filters
Showing results (1-10 of 50) with videos related to
Page
of 5
Sort By:
Journal of Thoracic Disease
|
October 30, 2018
Interleukin-1 beta inhibition with canakinumab and reducing lung cancer-subset analysis of the canakinumab anti-inflammatory thrombosis outcome study trial (CANTOS)
David Crossman, Alexander M K Rothman
American Journal of Respiratory and Critical Care Medicine
|
February 25, 2026
Target Engagement and Drug Delivery in PAH: Lessons from Inhaled Imatinib
Alexander M K Rothman, Mark Toshner, Martin R Wilkins
JACC. Basic to Translational Science
|
March 21, 2024
Radiation to Illuminate the Path of Neuromodulation for Pulmonary Hypertension
Karl-Philipp Rommel, Lukas Hobohm, Alexander M K Rothman, et al.
Pulmonary Circulation
|
December 7, 2020
Role of biomarkers in evaluation, treatment and clinical studies of pulmonary arterial hypertension
Anna Hemnes, Alexander M K Rothman, Andrew J Swift, et al.
European Journal of Heart Failure
|
June 2, 2020
Digital health care solution for proactive heart failure management with the Cordella Heart Failure System: results of the SIRONA first-in-human study
Wilfried Mullens, Faisal Sharif, Matthias Dupont, et al.
Pulmonary Circulation
|
April 8, 2026
Digital Data Collection Reduces Terminal Digit Bias in Haemodynamic and Physical Activity Measures in Pulmonary Arterial Hypertension
Alexander M K Rothman, Marcelle Paula-Ribeiro, Eleanor McNally, et al.
Pulmonary Circulation
|
October 20, 2025
Drug Development for Pulmonary Arterial Hypertension: Unleashing the Potential of Single-Patient Studies Using Continuous Monitoring
Martin R Wilkins, Sofia S Villar, James Wason, et al.
Circulation. Cardiovascular Interventions
|
January 13, 2016
Response to Letter Regarding Article, "Hemodynamic, Functional, and Clinical Responses to Pulmonary Artery Denervation in Patients With Pulmonary Arterial Hypertension of Different Causes: Phase II Results From the Pulmonary Artery Denervation-1 Study"
Shao-Liang Chen, Hang Zhang, Du-Jiang Xie, et al.
Circulation. Cardiovascular Interventions
|
November 11, 2015
Hemodynamic, functional, and clinical responses to pulmonary artery denervation in patients with pulmonary arterial hypertension of different causes: phase II results from the Pulmonary Artery Denervation-1 study
Shao-Liang Chen, Hang Zhang, Du-Jiang Xie, et al.
Pulmonary Circulation
|
April 20, 2026
Clinical Utility of the PHQ-2 and GAD-2 in Pulmonary Hypertension
Gregg H Rawlings, Jemma L Green, Alexander M K Rothman, et al.
Page
of 5
Search research articles
Search
Showing results (1-10 of 50) with videos related to
Sort By:
Page
of 5
Journal of Thoracic Disease
|
October 30, 2018
Interleukin-1 beta inhibition with canakinumab and reducing lung cancer-subset analysis of the canakinumab anti-inflammatory thrombosis outcome study trial (CANTOS)
David Crossman, Alexander M K Rothman
American Journal of Respiratory and Critical Care Medicine
|
February 25, 2026
Target Engagement and Drug Delivery in PAH: Lessons from Inhaled Imatinib
Alexander M K Rothman, Mark Toshner, Martin R Wilkins
JACC. Basic to Translational Science
|
March 21, 2024
Radiation to Illuminate the Path of Neuromodulation for Pulmonary Hypertension
Karl-Philipp Rommel, Lukas Hobohm, Alexander M K Rothman, et al.
Pulmonary Circulation
|
December 7, 2020
Role of biomarkers in evaluation, treatment and clinical studies of pulmonary arterial hypertension
Anna Hemnes, Alexander M K Rothman, Andrew J Swift, et al.
European Journal of Heart Failure
|
June 2, 2020
Digital health care solution for proactive heart failure management with the Cordella Heart Failure System: results of the SIRONA first-in-human study
Wilfried Mullens, Faisal Sharif, Matthias Dupont, et al.
Pulmonary Circulation
|
April 8, 2026
Digital Data Collection Reduces Terminal Digit Bias in Haemodynamic and Physical Activity Measures in Pulmonary Arterial Hypertension
Alexander M K Rothman, Marcelle Paula-Ribeiro, Eleanor McNally, et al.
Pulmonary Circulation
|
October 20, 2025
Drug Development for Pulmonary Arterial Hypertension: Unleashing the Potential of Single-Patient Studies Using Continuous Monitoring
Martin R Wilkins, Sofia S Villar, James Wason, et al.
Circulation. Cardiovascular Interventions
|
January 13, 2016
Response to Letter Regarding Article, "Hemodynamic, Functional, and Clinical Responses to Pulmonary Artery Denervation in Patients With Pulmonary Arterial Hypertension of Different Causes: Phase II Results From the Pulmonary Artery Denervation-1 Study"
Shao-Liang Chen, Hang Zhang, Du-Jiang Xie, et al.
Circulation. Cardiovascular Interventions
|
November 11, 2015
Hemodynamic, functional, and clinical responses to pulmonary artery denervation in patients with pulmonary arterial hypertension of different causes: phase II results from the Pulmonary Artery Denervation-1 study
Shao-Liang Chen, Hang Zhang, Du-Jiang Xie, et al.
Pulmonary Circulation
|
April 20, 2026
Clinical Utility of the PHQ-2 and GAD-2 in Pulmonary Hypertension
Gregg H Rawlings, Jemma L Green, Alexander M K Rothman, et al.
Page
of 5